Resultados da busca - Hope Qamoos
- Mostrando 1 - 4 resultados de 4
-
1
PB2198: TRIAL IN PROGRESS: AN OPEN-LABEL, GLOBAL, MULTICENTER, PHASE 1B/2 STUDY OF TL-895, A BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ADDED TO RUXOLITINIB (RUX) IN PATIENTS (PTS)... por Francesca Palandri, Stefanie Gröpper, Michaël Loschi, Marcelo Bellesso, Sebastian Grosicki, Pilar Giraldo, Claire Harrison, Tracy Clevenger, Nikki Stuart, Hope Qamoos, Gregory Vosganian, Wayne P. Rothbaum, Srđan Verstovšek, Pankit Vachhani
Publicado em 2023Artigo -
2
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas por Steven G. DuBois, Theodore W. Laetsch, Noah Federman, Brian Turpin, Catherine M. Albert, Ramamoorthy Nagasubramanian, Megan E. Anderson, Jessica L. Davis, Hope Qamoos, Mark Reynolds, Scott Cruickshank, Michael C. Cox, Douglas S. Hawkins, Leo Mascarenhas, Alberto S. Pappo
Publicado em 2018Artigo -
3
P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PL... por Michaël Loschi, László Rejtő, Hun Chuah, Marianna Caramella, Jesus Hernández Rivas, Paolo Sportoletti, Viviane Dubruille, Marcelo Bellesso, Stefanie Gröpper, Carl C. Crodel, Hope Qamoos, Ashley Socotch, Zhuying Huang, Sarah Wall, Jesse McGreivy, Wayne P. Rothbaum, Srđan Verstovšek, Francesca Palandri
Publicado em 2023Artigo -
4
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study por Carrie L. Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojčić, Courtney B. Betts, Lisa M. Coussens, Michael L. Meyers, Hope Qamoos, Peter Ordentlich, Vinit Kumar, Christine Quaranto, Aaron Schmitt, Yu Gu, Bruce R. Blazar, Trent Wang, Amandeep Salhotra, Iskra Pusic, Madan Jagasia, Stephanie J. Lee
Publicado em 2022Artigo
Ferramentas de busca:
Assuntos relacionados
Internal medicine
Medicine
Adverse effect
Biology
Bone marrow
Cohort
Gastroenterology
Genetics
Haematopoiesis
Immunology
Megakaryocyte
Myelofibrosis
Stem cell
Tolerability
Astrobiology
Cancer research
Chemotherapy
Clinical endpoint
Clinical trial
Graft-versus-host disease
Inflammation
Neurotrophin
Neutropenia
Oncology
Pathology
Physics
Platelet
Progressive disease
Proinflammatory cytokine
Receptor